U.S. Department of Health and Human Services
Clinical Trials Search Results
Search results 1 - 10 of 591 for FDA-Approved HIV Drugs, Truvada
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
NCT ID: NCT00625404- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
NCT ID: NCT00076791- Red stop iconCompleted
- Globe iconEn español
- Email this trial
Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
NCT ID: NCT01040091- Red stop iconCompleted
- Globe iconEn español
- Email this trial
GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
Condition: HIV Infections
NCT ID: NCT00362687- Red stop iconCompleted
- Email this trial
Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
NCT ID: NCT00448669- Red stop iconCompleted
- Email this trial
Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Condition: HIV Infections
NCT ID: NCT00762892- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV Seropositivity
NCT ID: NCT01813292- Red stop iconCompleted
- Email this trial
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
NCT ID: NCT00458393- Red stop iconCompleted
- Text file iconHas Results
- Globe iconEn español
- Email this trial
Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents
Condition: HIV Infections
NCT ID: NCT02213328- Red stop iconCompleted
- Email this trial
Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial
Condition: HIV Prevention
NCT ID: NCT03327155- Red stop iconActive, not recruiting
- Email this trial
Email Updates
